Outpatient monitoring of CAR T-cell therapy reduces healthcare resource utilization and hospital days without impacting 30-day mortality, finds ASCO study.

This feature explores evolving management strategies for bone sarcomas, highlighting multidisciplinary treatment approaches ...

PVR demonstrated superiority versus VR in the ITT analysis population; benefits consistent across prespecified subgroups.

Each additional hour per day of prolonged sedentary behavior is associated with a higher hazard of cancer death.

In this study, researchers aimed to evaluate patterns of engagement with health-related content on social media among US adults both with and without chronic conditions.

Using individual patient data from phase 2 and 3 trials, investigators analyzed the value of pathologic complete response vs ctDNA clearance after neoadjuvant immunotherapy or perioperative ...

Investigators conducted a retrospective analysis to determine whether postmenopausal women with a history of breast cancer can safely receive vaginal estrogen.

Early low-dose lenalidomide significantly reduces mutational burden without increasing AML risk in non-transfusion-dependent del(5q) MDS.

These results suggest that the demographic and clinicopathologic breast cancer characteristics observed in young Black women with breast cancer are comparable to those observed in White women, which ...

Tregzi (clinically known as Orca-T) is an allogeneic cellular immunotherapy consisting of purified regulatory and conventional T cells.

A real-world analysis investigates the impact of concurrent GLP-1 RA use on long-term survival and the safety profile of patients with solid and hematologic malignancies receiving immune checkpoint ...

In this study, the researchers aimed to identify 5- and 10-year relative survival outcomes for individuals aged younger than 20 years at the time of a cancer diagnosis.